Filing Flows › Rockwell Medical (RMTI) › Q2 2025
Rockwell Medical (RMTI) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Rockwell Medical (RMTI) reported revenue of $16.1M for the second quarter 2025 (Q2 2025), -38% from a year earlier and -15% from the quarter before. Operating margin was -8.4%, net loss $1.5M (9.3% of revenue).
Rockwell Medical, Q2 2025: revenue $16.1M (-38% year over year), operating margin -8.4%, net loss $1.5M, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.1M | -15% | -38% |
| Operating profit | −$1.3M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | $1.8M | — | +28% |
| Free cash flow | $1.7M | — | +45% |
What changed
Revenue was $16.1M in Q2 2025, down 38% year over year and down 15% from the previous quarter.
Gross margin was 15.6%, down 2.0 points from a year earlier. Operating costs exceeded revenue by $1.3M, an operating margin of -8.4%. Operating expenses fell 5% while revenue fell 38%. The quarter ended with a net loss of $1.5M, narrower than the previous quarter's $1.5M loss.
Operating cash flow was $1.8M (up 28% year over year). Non-cash charges added back $563K of depreciation and amortization and $382K of share-based compensation. Working capital and other items added $2.4M. Capital expenditures of $164K left free cash flow of $1.7M.
Questions
What was Rockwell Medical's revenue in the second quarter 2025?
Rockwell Medical (RMTI) reported revenue of $16.1M for the second quarter 2025 (Q2 2025), -38% from a year earlier and -15% from the quarter before.
Was Rockwell Medical profitable in the second quarter 2025?
Operating loss was $1.3M (-8.4% of revenue) and net loss $1.5M.
Source: Rockwell Medical 10-Q on SEC EDGAR.